Decibel Therapeutics Investors

44 investors on Angel Roster list Decibel Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name Decibel Therapeutics can appear together.

Investors listed
44
With verified email
48%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 Decibel Therapeutics investors

The most complete profiles first. Showing 40 of 44.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Krishna YeshwantVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    Series BHealth CareTelecommunicationsHospitalsE-commerce

    Portfolio: Pixie, Dialpad, Science 37, Synack and 90 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Brian BulgerVerified

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Jason MehringVerified

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Karim FarisVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareTelecommunicationsE-commerceConsumer Goods

    Portfolio: Pixie, Dialpad, Science 37, Synack and 87 more

    Verified email available

  • Matthew FoyVerified

    Corporate Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more

    Verified email available

  • Michael LeitnerVerified

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Charlie Guyton

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Daniel Nellis

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Kush Kothary

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Laurence Paredes

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

See all 44 Decibel Therapeutics investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many Decibel Therapeutics investors are on Angel Roster?

Angel Roster lists 44 Decibel Therapeutics investors. 21 of them (48%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (27), Private Equity Firms (23) and Investment Banks (9). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Decibel Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (21), Series A (5) and Series B (1).

Where are Decibel Therapeutics investors based?

Most are based in the United States (39), the United Kingdom (2) and Israel (2).

Which companies have Decibel Therapeutics investors backed?

The most-backed portfolio companies among them are Insitro (33), Olema Oncology (26), Goldfinch Biopharma (24), Relay Therapeutics (23) and Fulcrum Therapeutics (22).

How do I contact Decibel Therapeutics investors?

Create a free Angel Roster account to search and filter all 44, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.